With Bristol Myers Squibb (BMS) now rolling out the SC version of rival nivolumab (Opdivo Qvantig), the shift from 30-minute intravenous (IV) infusion to 5-minute SC injection could be one of the most ...
After receiving an injection, some people experience symptoms at the injection site on the skin. This reaction is a common adverse effect of vaccines, Botox injections, biologics, and chemotherapy.
The researchers have detailed their complete findings of subcutaneous (SC) vs intravenous (IV) efgartigimod in generalized myasthenia gravis (gMG) from the phase 3 ADAPT-SC trial and initial findings ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results